CytoAgents
Pittsburgh
About CytoAgents
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $21.5M
- Funding stage: Early Stage Venture
- Last round: Grant (Oct 2025)
- Website: cytoagents.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cytoagents-87645 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.